Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 2 Clinical characteristics of before and post-transplant patients

From: The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients

  Transplant stable (n = 13) Acute antibody mediated acute rejection (n = 8) Acute rejection (n = 7) Chronic rejection (n = 7)
  Before After Before After Before After Before After
BUN (mmol/L) 17.5 (7.2–32.8) 7.4* (3.7–10.6) 16.2 (10.1–28.4) 29.1* (22.3–38.9) 16.2 (14.4–20.6) 25.2* (17.9–34.7) 16.5 (9.2–22.6) 18.3* (13.5–26.8)
Cr (umol/L) 779 (499–1790) 130* (72–352) 798 (739–1682) 1387* (1098–1786) 789 (762–1562) 987* (794–1682) 786 (698–1492) 578* (512–755)
eGFR (ml/min) 20 (8–67) 88* (59–101) 27 (8–62) 9* (4–13) 21 (9–59) 12* (6–24) 24 (9–51) 18* (5–35)
WBC (×109/L) 9.8 (8.5–13.4) 7.9* (6.3–9.7) 9.7 (8.9–13.9) 17.7* (11.8–19.6) 9.6 (8.8–11.6) 13.1* (9.9–16.2) 9.7 (8.6–13.2) 11.7* (9.6–13.7)
PBMCs (×109/L) 1.7 (1.1–2.9) 0.8* (0.6–1.0) 1.7 (1.3–3.3) 0.3* (0.1–0.6) 1.9 (1.4–3.1) 0.7* (0.4–1.0) 1.7 (1.1–2.7) 0.7* (0.9–1.2)
RBC (×1012/L) 2.4 (2.1–2.7) 3.1* (2.6–3.3) 2.0 (1.7–2.5) 1.5* (1.3–2.0) 2.1 (1.9–3.1) 1.9* (1.7–2.3) 2.0 (1.9–2.9) 2.3* (2.0–2.8)
Hb (g/L) 86.0 (73.0–99.0) 97.0* (88.0–103.0) 82.0 (66.0–91.0) 73.0* (61.0–77.0) 87.0 (69.0–103.0) 78.0* (67.0–89.0) 84.0 (69.0–107) 91.0* (80.0–110.0)
  1. Data are expressed as median (range) or real case numbers
  2. * P < 0.05 vs, before transplant rejection